# A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

> **NCT01175226** · PHASE2 · COMPLETED · sponsor: **Biota Scientific Management Pty Ltd** · enrollment: 300 (actual)

## Conditions studied

- Rhinovirus

## Interventions

- **DRUG:** BTA798
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01175226
- **Lead sponsor:** Biota Scientific Management Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175226, "A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01175226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*